I would imagine that whatever is happening with Joondalup might get either sidelined or fast tracked after the RHC announcement of a substantial hit to earnings due to elective surgery and Covid etc. Joondalup is part of RHC and would either have its developments sidelined until some extra money hits the coffers (standard corporate action of cutting costs) or RHC might see HMDs tech as a competitive advantage which would be earnings accretive from day 1 of commercialisation.
Back to binary outcomes! RHC can’t cut costs and green light new expenditure so it probably falls onto the plate of the commercial manager or CFO etc… Regardless of trial outcomes, Joondalup is part of a business that is taking a pretty decent hit from Covid so.. dunno??
Mayo/Mednax/Barcelona/Sheba are all imminent and unknown? Sheba shares some senior staff with HMD so that muddies it a bit, can’t be seen to be too much of a conflict of interest.. same goes and more so for Mayo as they have a direct shareholding in HMD.. how conflicted is that?? How many extra protocols have to be cleared in order to anoint HeraBEAT as gold standard without also looking like they did just to earn some money from their investment?
all in all…. Dunno??
good luck mate and let’s hope something appears soon! Imagine how much fun it would be if someone dropped a HeraBEAT on the ground somewhere in WA and it turned out to be the worlds best Lithium detector!!! Then we would be worth BILLIONS in a heartbeat!!
HMD Price at posting:
25.0¢ Sentiment: Buy Disclosure: Held
